(in alphabetical order)


Theodore P. Abraham, MD, FACC, FASE

Director, Hypertrophic Cardiomyopathy Center of Excellence, Johns Hopkins Medicine

Dr. Abraham earned his medical degree from University of Bombay. He completed internal medicine residency at Wake Forest University, followed by a cardiovascular fellowship at University of Texas Southwestern Medical Center in Dallas and an advanced fellowship in echocardiography and cardiac mechanics at the Mayo Clinic in Rochester, Minnesota. He was on faculty at the Mayo Clinic before coming to Johns Hopkins University in 2004 as the associate director of the Johns Hopkins Echocardiography Laboratory. He also started and currently directs the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. In 2009, he was appointed vice chief of the Division of Cardiology.

The Abraham research laboratory is involved in translational and clinical research related to hypertrophic cardiomyopathy and the use of novel cardiac mechanics imaging in various cardiac pathologies. Abraham currently serves on the national Board of Directors of the American Society of Echocardiography and on the editorial boards of four premier biomedical journals. He has published numerous research articles and book chapters, has mentored several postdoctoral fellows, and is the editor-in-chief of the Case-based Handbook of Echocardiography.


Denis Buxton, PhD

Director of the Basic and Early Translational Research (BETR) Program and Associate Director of the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute (NHLBI)

After obtaining his Ph.D. at University College, London, Dr. Buxton went to the University of Texas Health Science Center in San Antonio to work on substrate metabolism. As an associate professor of pharmacology at UCLA, he studied cardiac ischemia and reperfusion using positron emission tomography. He came to NHLBI via the intramural program, where he worked on signal transduction and non-muscle myosins. In his current position he manages the NHLBI Programs of Excellence in Nanotechnology and the NHLBI Progenitor Cell Biology Consortium, and oversees Phase I and II clinical trials in cardiovascular stem cell therapy.

Byrd_Ben 300x399

Benjamin F. Byrd III, MD, FACC, FASE

Professor of Medicine, Division of Cardiology, Vanderbilt University School of Medicine

Dr. Byrd was born in Nashville and, after graduating from Princeton University with a degree in History in 1973, followed in the footsteps of his father and grandfather by graduating from the Vanderbilt University School of Medicine in 1977. He is well-known in the field as a speaker on adult congenital heart disease and valvular heart disease. He joined the Department of Medicine in Cardiology at Vanderbilt in 1984 as Director of the Echocardiography Laboratory.

Dr. Byrd introduced transesophageal and stress echocardiography to Vanderbilt, and was a co-founder of its Adult Congenital Heart Clinic, which he directed for over two decades. He has been a Professor of Medicine at Vanderbilt University since 2002. Dr. Byrd has devoted many years to volunteer activities at ASE and other cardiology organizations, and recently completed his term as President of ASE. In 2009 he received the ASE Meritorious Service Award, which recognizes individual members for their substantial and generous efforts to the Society’s betterment.


Anthony V. Coletta, MD, MBA

President and CEO of Tandigm Health

Dr. Coletta is President and CEO of Tandigm Health, a groundbreaking joint venture by Independence Blue Cross (Independence) and Davita Health Care Partners, which will work in tandem with primary care physicians to create a new paradigm of high-quality, affordable health care in the Philadelphia region. Dr. Coletta was previously a SVP of Independence where he served as one of the principal architects of the Tandigm Health business plan.

Prior to Independence, Dr. Coletta was EVP and CMO of Holy Redeemer Health System in Huntingdon Valley, PA. Previously, he led the creation in 2000 of Renaissance Health Alliance, a joint venture between Independence and Renaissance, a large, Philadelphia-based Independent Practice Association, where Dr. Coletta served as CEO and chairman of the board.

Dr. Coletta was an attending general surgeon in private practice for 25 years at Bryn Mawr Hospital, and an associate clinical professor of surgery at Drexel University in Philadelphia. He is recognized as a pioneer in minimally invasive surgery and has been recognized as a Top Doctor in the Philadelphia region throughout his career.
Since 2007, Dr. Coletta has volunteered as a surgical missionary to Haiti, traveling there annually with medical supplies and a team of physicians.

Dr. Coletta received his BS degree in chemistry at Georgetown University and graduated from Thomas Jefferson Medical College in 1979. He completed his Surgical Residency and a Fellowship in Organ Transplantation at Thomas Jefferson University Hospital. A Fellow in the American College of Surgeons, he attained his MBA from the Fox School of Business at Temple University in 2006 with the distinction of University Scholar.


Representative Jim Cooper (TN-05)

United States Congressman

Rep. Cooper is serving his twelfth term in Congress and currently represents Tennessee’s 5th district, which includes Nashville and surrounding counties. He is a member of the Armed Services and Oversight and Government Reform Committees. Cooper has been a leading voice in the health care debate for over two decades and is an adjunct professor at Vanderbilt University’s Owen Graduate School of Business where he has taught courses on health care policy for fifteen years. Prior to his election to Congress, Cooper was an attorney and worked in finance. He has a bachelor’s degree in history and economics from the University of North Carolina at Chapel Hill, earned a bachelor’s and master’s degree in politics and economics as a Rhodes Scholar at Oxford University, and received a juris doctorate from Harvard Law School.


Anthony J. Dean, MD

Director of the Division of Emergency Ultrasound at the University of Pennsylvania

Dr. Dean has been the Director of the Division of Emergency Ultrasound at the University of Pennsylvania since 2001. The Division is responsible for emergency medicine resident training, a one- and two-year fellowship program, as well as training for Pulmonary and Trauma Critical Care Fellows at PENN, and Pediatric Critical Care and Emergency Medicine Fellows at the Children’s Hospital of Philadelphia. Within the Perelman School of Medicine at the University of Pennsylvania, he teaches point-of-care ultrasonography in a series of modules that are integrated into the 4-year medical school curriculum. Dr. Dean has a strong interest in international emergency medicine and global health systems science, and the use of ultrasonography in resource-poor settings. He is a founding member and on the Boards of the World Interactive Network for Critical Ultrasound (WINFOCUS) and Point-of-Care Ultrasound in Resource-Limited Environments (PURE).


Pamela S. Douglas, MD, MACC, FASE, FAHA

Director, Imaging Program, Duke Clinical Research Institute Ursula Geller Professorship for Research in Cardiovascular Diseases

Dr. Douglas is the Ursula Geller Professorship for Research in Cardiovascular Diseases at Duke University, having previously served on the faculties of the University of Pennsylvania, Harvard University, and the University of Wisconsin. Douglas has served as CV Chief at two premier universities (Duke, Wisconsin) and as a past president of the American College of Cardiology and of the American Society of Echocardiography.

Douglas is internationally known for her scientific work in noninvasive imaging, exercise physiology, and heart disease in women. Her contributions in imaging span an enormous range, from technological innovation to health care delivery, including shaping a national program for quality improvement in imaging. Dr Douglas also had a significant role in creating the field of heart disease in women as an early and persuasive champion of its distinctive importance and relevance.


Linda D. Gillam, MD, MPH

Chair of Cardiovascular Medicine for Morristown Medical Center/ Atlantic Health System

Dr. Gillam has published and lectured extensively in the fields of echocardiography, valvular heart disease and heart disease in women. She is Associate Editor for Circulation: Cardiovascular Imaging, and co-editor (with Catherine Otto, MD) of Advanced Echocardiographic Techniques.

Dr. Gillam is Past President of the ASE, President-Elect of the National Board of Echocardiography, and a former member of both the Board of Trustees and Board of Governors of the ACC. She has had multiple other leadership roles in these and other organizations.

Past awards include the ASE Richard Popp Distinguished Teacher Award, the AHA Women in Cardiology Mentoring Award, the ACC Distinguished Service Award, the ASE Meritorious Service Award and the Laennec Lectureship Award of the AHA.

She is also a member of the CMS Medicare Coverage Advisory Committee and the Brookings Technical Expert Panel for cardiology payment reform. She previously served as an advisor to the FDA.


Steven A. Goldstein, MD

Director of Noninvasive Cardiology, Washington Hospital Center, Washington, DC

Dr. Goldstein is a longtime member of the medical community in Washington, D.C., having joined the faculty at Washington Hospital Center in 1978 and served as the Director of Noninvasive Cardiology there since 1980. He has also been recognized multiple times for his dedication to teaching, as a recipient of the Excellence of Teaching Award of the Department of Medicine in 1987. He was also the recipient of the Excellence of Teaching Award of the Department of Cardiology of Georgetown/Washington Hospital Center in 2007, 2009, and 2013, and was honored with the prestigious Gold-Headed Cane Award at the Washington Hospital Center for devotion to duty and patient care.

Dr. Goldstein’s major areas of interest are clinical cardiology and echocardiography (ultrasound of the heart), especially diseases of the aorta, valvular heart disease, and the role of echocardiography for guiding procedures in the Cath Lab. He is a past Governor of the American College of Cardiology (DC Chapter), past Board Member of the American Society of Echocardiography, and past Vice President of the American Heart Association (DC Chapter). He is a past Vice President of the National Board of Echocardiography and Chairman of the Item Writing Committee. He is on the editorial board of the American Journal of Cardiology and the Journal of the American Society of Echocardiography, and serves on several committees of the American Society of Echocardiography.


Thomas Graf, MD

Chief Medical Officer for Population Health and Longitudinal Care Service Lines for Geisinger Health System

Dr. Graf is responsible for the Value Re-Engineering of the Care Continuum and other population health initiatives for Geisinger, including the ACO portfolio and with CMS, the Physician Group Practice Transitions Demonstration and Bundled Payments for Care Improvement. He leads the Community Practice, Internal Medicine, Pediatrics, Psychiatry and Care Continuum Service Lines in coordinating and accelerating population health related activities across 22 counties in central and northeast Pennsylvania. He is recognized nationally as a leader in medical home and post-acute care redesign.


Kenneth D. Horton, RCS, FASE

Echo/Vascular Research Coordinator, Intermountain Heart Institute

Ken Horton is a Navy-trained Cardiovascular Technician who has specialized in echocardiography since 1989. He served in the Navy for 20 years which included a 9-year tour as instructor and Program Director of the Navy’s Cardiovascular Training Program in Bethesda, Maryland. Since retiring he has held multiple clinical and research sonographer positions at MedStar Georgetown University Hospital, University of Virginia Medical Center and MedStar Health Research Institute. He currently coordinates clinical echocardiography research at the Intermountain Medical Center in Murray, Utah.

Ken currently serves on the executive committee of Cardiovascular Credentialing International, where he is President Elect, and he also serves as the Secretary of the Executive Committee of the American Society of Echocardiography. He has served on multiple committees within the ASE including the Editorial Board of the Journal of the American Society of Echocardiography and as the Chair of the Council of Cardiovascular Sonography. He has authored or co-authored several peer-reviewed manuscripts and book chapters related to echocardiography, and is an invited lecturer at both national and international sonography meetings.


Alexis A. Isenberg, P.E.

Principal and Owner, The Lexis Group, LLC

Ms. Alexis Isenberg graduated cum laude with a Bachelor’s of Science Degree in Civil Engineering from Bucknell University in 1994. As Principal and Owner of The Lexis Group, LLC, a certified woman-business enterprise, Ms. Isenberg is responsible for all aspects and operations of the firm which specializes in structural/civil engineering, landscape architecture, and land planning. In April 2010, at the age of 38, Alexis was diagnosed with Stage 3 invasive breast cancer, and subsequently underwent a double mastectomy, two years of chemotherapy, eight weeks of radiation, two breast reconstructions, and a total hysterectomy. She also participated in an eight-month long clinical vaccine trial at John Hopkins for HER2 positive breast cancer patients, which often required driving seven days a week to Baltimore from her home in Dillsburg, Pennsylvania.

Alexis is involved in numerous organizations, from fund-raising for a new playground at her daughter’s elementary school, volunteering as the Chairman of her Township Planning Commission, sitting on the Board of Directors of the Pennsylvania Society of Professional Engineers, to raising almost $34,000 for the American Cancer Society and Susan G. Komen Foundations. She is a survivor whose armor has been her humor, her make-up, her high heels, and the support of her friends and family; in her own words, “I am a work in progress. Stay tuned.”

Klein 2013

Allan L. Klein, MD, FASE

Director of the Center for the Diagnosis and Treatment of Pericardial Diseases at the Cleveland Clinic

Dr. Allan Klein has spent the past 25 years at the renowned Cleveland Clinic. He is the Director of the Center for the Diagnosis & Treatment of Pericardial Disease and Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western University. In addition to his clinical and research work, he has also served as the Course Director for Diastology and Contrast Echo & New Technologies Courses. His specialty interests include cardiovascular imaging, pericardial diseases, restrictive cardiomyopathies, valvular heart disease, atrial fibrillation, and diastolic heart failure.

A Canadian by birth, Dr. Klein speaks fluent French and English. He received his medical degree from McGill University in Montreal, Quebec and won the E.G.D. Murray Prize in Microbiology and Immunology as an undergraduate; he has also received multiple ASE Outcomes Research Awards.

He is also principal or co-principal investigator for several multicenter clinical trials, and was honored to present the first online video summary of the ROTEA study for the Journal of the American Society of Echocardiography. He has published key articles in such prestigious journals such as New England Journal of Medicine, Lancet, European Heart Journal, Circulation, and the Journal of the American College of Cardiology. He is a co-editor of 2 books entitled “Diastology: Clinical Approach to Diastolic Heart Failure.” as well as “Clinical Echocardiography Review: A Self-Assessment Tool.”

Dr. Klein serves on the Board of Directors of ASE and was recently elected as Vice President of the Society. He has chaired several committees in the past, including the Guidelines and Standards Committee and the Industry Relations Committee. He recently served as Chair of the writing committee for a new ASE guideline entitled “Clinical Recommendations for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease.” He is also on the Writing Committee for the National Board of Echocardiography (NBE) and serves as peer reviewer for more than 15 professional journals. Dr. Klein has been an invited lecturer at many national and international symposia and conferences, speaking on topics related to his specialty interests.


Joseph Kreeger, RCCS, RDCS, FASE

Technical Director, Echocardiography Laboratory, Children’s Healthcare of Atlanta

Joe is the technical director of the echocardiography lab at Children’s Healthcare of Atlanta. His clinical background is in pediatric and fetal echocardiography, as well as adult-congenital echocardiography. He has been a subject matter expert for the ARDMS pediatric and fetal echocardiography specialty exams, as well as the CCI pediatric/adult congenital specialty exam. He currently serves on the ASE Executive Committee as the Member-at-Large, as well as the Telemedicine and New Technology Taskforce for ASE, and previously was the sonographer representative to the Pediatric and Congenital Heart Disease Council. Joe has held an active registry status since 1995 and holds credentials in adult, pediatric, and fetal echocardiography by the ARDMS as well as the congenital echocardiography credential by CCI.

Joe is an accomplished educator in the echocardiographic evaluation of complex congenital heart disease in pediatric, fetal, and adult congenital patients and has been instrumental in training fellows of the very robust Sibley Heart Center cardiology fellowship program at Children’s Healthcare of Atlanta.


Randolph P. Martin, MD, FACC, FASE, FESC

Chief, Valvular & Structural Heart Disease Center of Excellence| Physician Principal Advisor, Educational Programs Marcus Heart Valve Center, Piedmont Heart Institute

Dr. Martin is one of the pioneers in the field of Noninvasive Cardiology, using ultrasound – echocardiography – to diagnose cardiovascular conditions. He attended Emory University School of Medicine, graduating summa cum laude in 1969, and went on to hold faculty positions and clinical staff positions at Stanford University, the University of Virginia, the Mayo Medical School and Mayo Clinic, and Emory University, where he served as Professor of Medicine and Director of Noninvasive Cardiology for 20 years.

Dr. Martin has lectured extensively throughout the world, and for 21 years served as the Host/Moderator of the world’s largest professional medical satellite tele-education program, “Echo in Context.” He also served for 15 years as the sole Medical Correspondent for Cox Communications’ affiliate – WSB-TV, Channel-2, in Atlanta. Dr. Martin was awarded multiple broadcast awards, including three Emmy nominations, and also won the American Heart Association’s Howard L. Lewis Lifetime Achievement Award for Health Reporting – becoming the first physician television journalist to do so.

Dr. Martin has long had a keen interest in consumer education. Beginning in 1994, he was the director of Emory’s nationally-recognized Mini-Medical School – a nearly year-long course for consumers to emulate medical school experience. Over 7000 citizens of Atlanta graduated from Dr. Martin’s Mini-Medical School. In partnership with Piedmont Healthcare, Dr. Martin launched HealthWatchMD.com in 2011, expanding his audience and disseminating up-to-the-minute health news to the Atlanta Community and beyond.


Susan M. Nedza, MD, MBA, FACEP

Chief Medical Officer, AIM Specialty Health, Inc.

Dr. Susan Nedza currently serves as the Chief Medical Officer for AIM Specialty HealthSM (a wholly owned WellPoint subsidiary). In her role, she has direct responsibility for the AIM Clinical Appropriateness Guidelines and leads a team of physician experts. Dr. Nedza’s broad experience as a board-certified emergency medicine specialist, Chief Medical Officer at the Centers for Medicare and Medicaid Services, Senior Executive at the American Medical Association, and Health Information Technology Executive has given her a unique vantage point at the confluence of clinical care, health care delivery systems, payment policy, and health care policy.

While at CMS, she led efforts to implement the Medicare Drug Benefit at the regional level and designed and implemented the Physician Quality Reporting Initiative (now the PQRS). At the AMA, she was responsible for the development of cross-specialty performance measures that have been widely adopted by the CMS as well as private health plans. Prior to joining AIM, she led efforts to build health information technology to deliver evidence-based shared decision support tools. Her research on behalf of the Robert Wood Johnson Foundation studied the role that professional organizations play in supporting physician adoption of health information technology. She currently serves on the American College of Emergency Physicians (ACEP) Cost-Effective Care Task Force and is a past member of the ACEP Board of Directors.


Amol Navathe, MD, PhD

Managing Director, Navigant Consulting, Inc.

Amol Navathe, a Managing Director with Navigant’s Healthcare practice, is a practicing physician, health economist and engineer with expertise in the utilization of advanced health data analytics and technology to improve healthcare delivery. He has contributed to revolutionary ideas involving delivery transformation and innovation, federal policy for health data infrastructure development, and the study of physician and hospital economic behavior. Amol has authored many articles on these topics. He is considered a trusted advisor to his clients, including the U.S. government.

His thought leadership inspired the founding of the new journal Health Care: the Journal of Delivery Science and Innovation, for which he serves as its Co-Editor-in-Chief. It is the first peer-reviewed journal focused exclusively on delivery science and care redesign. Amol is also the Founding Director of the Foundation for Healthcare Innovation, of which the journal is a product.


Patricia A. Pellikka, MD, FACC, FACP, FAHA, FASE

Professor of Medicine at Mayo Clinic College of Medicine and Director of the Echocardiography Laboratory at Mayo Clinic

Dr. Pellikka has spent most of her medical career at Mayo Clinic, which was recently awarded the coveted title of Best Hospital by U.S. News & World Report in the 25th annual edition of its rankings. She was the recipient of the 2013 Outstanding Mentorship Award from Mayo Clinic Department of Medicine, and served as President of the American Society of Echocardiography from 2012-2013. Her research involves using echocardiography to assess cardiac function and improve patient outcomes. She has authored more than 300 peer-reviewed articles and chapters and her research has been funded by the NHLBI, American Heart Association, American Society of Echocardiography, Intersocietal Accreditation Commission, and Mayo Foundation. She has served on the Editorial Boards of several major cardiology journals, and is listed among the Best Doctors in America.


Michael H. Picard, MD, FACC, FASE, FAHA

Director of Echocardiography at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Dr. Picard is active in many multicenter NHLBI sponsored clinical trials and directs the echocardiography core labs for several, including the PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial. His research interests are in the novel applications of echocardiography in coronary artery disease, translational cardiology and valvular heart disease, and he is recognized as an authority on Arrhythmogenic RV Cardiomyopathy/Dysplasia.

Dr. Picard has helped develop the Appropriateness Criteria for Transthoracic and Transesophageal Echocardiography and those for Multimodality Cardiac Imaging in Heart Failure, in addition to numerous other guidelines papers. He has also recently performed research to investigate methods to improve appropriateness of ordering of diagnostic tests in cardiology. He has been awarded the Young Investigator Award from the American College of Cardiology and the Richard Popp Award for Excellence in Teaching from the American Society of Echocardiography. He has also served on the Medicare Advisory Committee (2003-2006) and on numerous occasions has presented to the AMA Relative Value Update Committee (RUC).


John C. Pilotte

Director of the Performance-Based Payment Policy Group in the Center for Medicare at the Centers for Medicare & Medicaid Services

John manages a team of analysts responsible for implementing the Medicare Shared Savings Program for Accountable Care Organizations, the Physician Feedback Program and Value Based Payment Modifier for physician groups, and measuring cost efficiency for Hospital Value Based Purchasing Program. The team also provides guidance and technical assistance on the design, development and implementation of other value based purchasing initiatives. Previously, John was the Director of the Division of Payment Policy Demonstrations at CMS where he led the development and implementation of the Physician Group Practice and Physician Group Practice Transition Demonstrations. Prior to joining CMS, he was a senior consultant with PricewaterhouseCoopers health care practice; and an associate on the government relations staff of the National Association of Children’s Hospitals and Related Institutions. He has a Masters in Health Policy and Management from The Johns Hopkins University and a Bachelors of Science from Indiana University.


Thomas J. Ryan, MD, FACC, FASE

Director, Ohio State University Heart and Vascular Center John G. and Jeanne Bonnet McCoy Chair in Cardiovascular Medicine

Dr. Ryan, Director of Ohio State’s Heart and Vascular Center, leads a talented team of specialists, physicians, nurses, technicians, researchers, fellows and residents. Formerly the Director of the Duke University Heart Center, Dr. Ryan is a national expert on cardiac ultrasound technology and holds the John G. and Jeanne Bonnet McCoy Chair in Cardiovascular Medicine. Additionally, Dr. Ryan holds appointments as professor of internal medicine and physician-scientist leader for Ohio State’s Wexner Medical Center’s heart signature program.

A longtime researcher, Dr. Ryan’s work emphasizes the application of cutting-edge echocardiographic techniques to clinical diagnosis. He is a principal investigator on numerous clinical trials examining the use of contrast agents for evaluating ventricular function and blood flow in conjunction with stress echocardiography.

Dr. Ryan is a past president of the American Society of Echocardiography, and has served as associate editor of the American Heart Journal and the Journal of the American Society of Echocardiography. He is co-author of Feigenbaum’s Echocardiography, the leading textbook in the field of cardiovascular ultrasound. He has participated in more than 30 funded research projects, delivered more than 140 invited lectures throughout the world, and has mentored numerous cardiology fellows and doctoral students in cardiovascular imaging research.

Rychik JackRGB1-13

Jack Rychik, MD, FACC

Professor of Pediatrics, Perelman School of Medicine of the University of Pennsylvania
Associate Chief of the Division of Cardiology, The Children’s Hospital of Philadelphia

Dr. Rychik is the holder of the Robert and Dolores Harrington Endowed Chair in Pediatric Cardiology at The Children’s Hospital of Philadelphia, where he has been on staff in the division of cardiology for the past 23 years. He is Director of the Fetal Heart Program, one of the largest dedicated prenatal clinical services in North America, with over 3500 fetal echocardiograms performed annually. Dr. Rychik has been instrumental in developing diagnostic criteria and management protocols for prenatal conditions such as complex forms of congenital heart disease. Dr. Rychik is also director of the Single Ventricle Survivorship Program, a multidisciplinary program which focuses on comprehensive sub-specialty services offered to assess the circulation of children and young adult survivors with single ventricle type of complex heart disease.

Dr. Rychik is editor of the book “Hypoplastic Left Heart Syndrome” and most recently editor/author of the book “Fetal Cardiovascular Imaging,” a compendium of knowledge and an atlas library of video images on the subject of prenatal heart disease. Dr. Rychik has been invited to numerous meetings and conferences nationally and around the world, and has had the opportunity to lecture regularly and develop collaborative relationships at a number of institutions in mainland China. Dr. Rychik lives in Merion, Pennsylvania with his wife Susan and his three daughters Jordana, Leora and Natali.


Partho P. Sengupta, MBBS, MD, DM, FASE

Director of Cardiac Ultrasound Research and Core Lab, Mount Sinai Medical Center

Dr. Sengupta is the Director of Cardiac Ultrasound Research and Core Lab and an Associate Professor of Medicine in Cardiology at Mount Sinai’s Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health. He completed his clinical residency and cardiology fellowship from Mayo Clinic Rochester and Arizona respectively, and has over 100 peer-reviewed publications. The primary goal of his research is to detect early stages of cardiovascular disease using state-of-the-art cardiac ultrasound technologies.

Prior to his move to Mount Sinai New York, he served as the Director of Noninvasive Cardiology and Cardiac Imaging at University of California, Irvine. He is an Associate Editor for the Journal of American College of Cardiology: Imaging and currently serves on the Board of Directors for the American Society of Echocardiography (ASE) and as the Chair of the 2014 ASE Telehealth and New Technology Taskforce.

Dr. Sengupta has won several excellence awards including ASE’s Young Investigator Award in 2004, Mayo Clinic Research Award in 2007, Mayo Brother’s Distinguished Fellowship Award in 2009 and AACIO Young Investigator Award in 2010. Most recently, he was honored with ASE’s 14th Annual Feigenbaum Lecturership in recognition of his significant contributions to research in the field of echocardiography. He delivered ASE’s first-ever presentation using hologram technology at ASE’s 24th Annual Scientific Sessions on July 1, 2013 in Minneapolis, Minnesota. His futuristic ideas, investigative skills and international work have been widely acclaimed by major media outlets including heart.org and Forbes.


James D. Thomas, MD, FACC, FASE

Director of the Center for Heart Valve Disease at the Bluhm Cardiovascular Institute, Northwestern University

Dr. Thomas recently joined Northwestern Medicine as the new Director of the Center for Heart Valve Disease at the Bluhm Cardiovascular Institute, after more than two decades at the renowned Cleveland Clinic, where he served as the Charles and Lorraine Moore Chair in Cardiovascular Imaging and professor of Medicine and Biomedical Engineering at Case Western Reserve University. He also continues to serve as the Lead Scientist for Ultrasound with NASA, studying the effects of microgravity on astronauts’ hearts and helping train them in the use of cardiac ultrasound in space.

Dr. Thomas has more than 500 peer reviewed publications; his clinical interests include valvular heart disease and diastolic dysfunction, with research interests in cardiac mechanics, application of new echo technology and space physiology. Dr. Thomas is a member of the American College of Physicians, American College of Cardiology and the American Society of Echocardiography (ASE), and a fellow of the Council on Clinical Cardiology, American Heart Association and the European Society of Cardiology.

Dr. Thomas is a Past President of ASE, and has served on numerous committees over the years. Currently, he is serving as Co-Chair of the joint EACVI-ASE-Industry Initiative to Standardize Deformation Imaging, which has produced a consensus document to be published in an upcoming issue of JASE, entitled “Definitions for a Common Standard for 2D Speckle Tracking Echocardiography.”
Dr. Thomas is also ASE’s spokesperson for the ABIM Foundation’s Choosing Wisely© campaign, and serves on the ACC’s Imaging Council as ASE’s representative. He is a recipient of the Richard Popp Excellence in Teaching Award from the American Society of Echocardiography and was honored as the Edler Lecturer at ASE’s Scientific Sessions in 2013.


William Wallace

Executive Director of US Ignite

William Wallace is Executive Director of US Ignite, a non-profit organization that fosters the creation of next-generation Internet applications. He brings to US Ignite more than 30 years of experience in the telecommunications industry, most recently as co-founder of DigitalBridge Communications (DBC), a venture-backed startup dedicated to bringing 4G broadband wireless services to underserved portions of the U.S. Prior to DBC, Mr. Wallace was co-founder and CEO of OnePoint Communications, which was purchased by Verizon Communications in 2000. OnePoint and its successor company, Verizon Avenue, provide bundled communications services to concentrated communities nationwide, including apartment communities, military bases, and rural areas.

 Parker Ward1

R. Parker Ward, MD, FACC, FASE, FASNC

Professor of Medicine; Director, Cardiovascular Fellowship Program, University of Chicago Medicine

Dr. Ward is a Professor of Medicine (Cardiology)/Radiology at the University of Chicago, Pritzker School of Medicine, and serves as Director of the Cardiovascular Disease Fellowship Training Program and Director of Nuclear Cardiology at the University of Chicago Medicine. He is an expert in multi-modality cardiovascular imaging and a long-time practitioner and researcher in the Non-invasive Imaging Laboratories at U of C. Dr. Ward has helped develop the Appropriate Use Criteria (AUC) for a variety of cardiovascular imaging modalities and has published extensively in the areas of AUC implementation and effectiveness, and the role of cardiovascular imaging in optimizing cost-effective patient care. Dr. Ward has been nationally recognized for his contributions as an educator and investigator and is a frequent lecturer on issues of cardiovascular imaging cost, value, and quality.

Weissman, Neil J headshot

Neil J. Weissman, MD, FACC, FASE

President of MedStar Health Research Institute

Dr. Weissman is President of MedStar Health Research Institute, Professor of Medicine at Georgetown University School of Medicine and Director of the Cardiovascular Core Laboratories at MedStar Washington Hospital Center in Washington, DC. His ultrasound core laboratory has served as a site for more than 250 multi-center trials, and Dr. Weissman is currently the national principal investigator on cardiac safety studies with more than 7,000 participants. Internationally recognized as an expert in cardiac ultrasound, Dr. Weissman serves as an advisor on the Food and Drug Administration’s Cardio-Renal Advisory Committee, is a frequent author of cardiovascular guidelines, and is on editorial boards for various internationally recognized journals.


David H. Wiener, MD, FACC, FAHA, FASE

Clinical Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University and Director of Clinical Operations at the Jefferson Heart Institute

In his role at the Jefferson Heart Institute, Dr. Wiener administers a large, integrated hospital- and outpatient-based academic cardiology practice, and is a practicing clinical cardiologist and echocardiographer. He recently published a special article exploring ways to ensure delivery of high value cardiac imaging. As Chair of ASE’s Advocacy Committee, he is experienced with the legislative and regulatory aspects of cardiovascular imaging.


Sarah Woodruff

ACHA Heart2Heart Ambassador

Sarah was born with Shone’s syndrome (aortic coarctation, bicuspid aortic semilunar valve, insufficient mitral valve muscles). A fall out of bed when she was four landed her in the emergency room for a concussion. The doctor’s questions about her “heart condition” came as a complete surprise. A few days later she was seen at Children’s National Medical Center in Washington, D.C., and a month later, her coarcted aorta was repaired. That was the fall of 1982 and she has been in cardiac care ever since. By spring 2010, her aortic root had dilated to the point that valve-sparing aortic root replacement was necessary and in the future new valves may also be needed. New scars, more stories, better health! She is a spouse, a parent, a daughter, a friend, a statistician, a teacher, and an adult who does what she needs to in order to thrive with CHD.


ECHOVATION SUBMISSION DEADLINE EXTENDED! If you have an innovative solution to improve cardiovascular ultrasound, it’s not too late to submit your idea for a chance to share in the $10,000 prize money! Visit https://herox.com/echovation-challenge-2018 to find out what’s required, register as an innovator, and submit your proposal 11:59 PM ET on February 23!